Methyl 4-amino-1H-indazole-6-carboxylate is primarily utilized as a key intermediate in pharmaceutical research and development for synthesizing biologically active molecules, such as anti-cancer and anti-inflammatory agents. Its structure, featuring amino and ester functional groups on an indazole core, allows for modifications to enhance drug efficacy and specificity. Researchers employ it to study mechanisms of action and biological effects, optimizing novel indazole-based therapeutics targeting enzymes or receptors for various diseases.